Overview
Muhammad Riaz is a Hematologist practicing medicine in Fort Thomas, Kentucky.
Dr. Riaz is highly rated in 4 conditions, according to our data. His clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Muscle Invasive Bladder Cancer, Shwartzman Phenomenon, and Venous Thromboembolism (VTE).
He is actively involved in clinical research, co-authoring 19 peer reviewed articles and participating in 7 clinical trials. Dr. Riaz is currently accepting new patients.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- HMO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- EPO
- HMO
- PPO
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
85 N Grand Ave, Fort Thomas, KY 41075
1 Medical Village Dr, Edgewood, KY 41017
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
7 Clinical Trials
Hoxworth Center
John Byrd is a Hematologist practicing medicine in Cincinnati, Ohio. Dr. Byrd is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Byrd is currently accepting new patients.
Cincinnati Children's Hospital Medical Center
Kasiani Myers is a Hematologist and an Oncologist practicing medicine in Cincinnati, Ohio. Dr. Myers is highly rated in 22 conditions, according to our data. Her clinical expertise encompasses Shwachman-Diamond Syndrome, Congenital Aplastic Anemia, Fanconi Anemia, Aplastic Anemia, and Bone Marrow Transplant. Dr. Myers is currently accepting new patients.
Cincinnati Children's Hospital Medical Center
Russell Ware is a Hematologist and an Oncologist practicing medicine in Cincinnati, Ohio. Dr. Ware is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemolytic Anemia, Anemia, and Splenectomy. Dr. Ware is currently accepting new patients.
Frequently Asked Questions about Dr. Muhammad K. Riaz
How do I make an appointment with Dr. Muhammad K. Riaz?
You can book an appointment with Dr. Muhammad K. Riaz by calling their office at 859-572-3298. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Muhammad K. Riaz a top-rated expert for ALK-Positive Non-Small Cell Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Muhammad K. Riaz is classified as an Distinguished expert for ALK-Positive Non-Small Cell Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Muhammad K. Riaz specialize in?
While Dr. Muhammad K. Riaz is a Hematology, they have specific expertise in ALK-Positive Non-Small Cell Lung Cancer, Muscle Invasive Bladder Cancer, and Shwartzman Phenomenon. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Muhammad K. Riaz participate in research or clinical trials?
Yes. Dr. Muhammad K. Riaz has published 19 articles and abstracts on conditions like ALK-Positive Non-Small Cell Lung Cancer. You can view a list of Dr. Muhammad K. Riaz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Muhammad K. Riaz accept my insurance?
Dr. Muhammad K. Riaz accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 859-572-3298 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Riaz isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Advanced
- Muscle Invasive Bladder Cancer
- Shwartzman PhenomenonDr. Riaz isAdvanced. Learn about Shwartzman Phenomenon.
- Venous Thromboembolism (VTE)Dr. Riaz isAdvanced. Learn about Venous Thromboembolism (VTE).
- Experienced
- Adult Immune ThrombocytopeniaDr. Riaz isExperienced. Learn about Adult Immune Thrombocytopenia.
- Hemangioma Thrombocytopenia Syndrome
- Immune Thrombocytopenic Purpura (ITP)
- Lung NodulesDr. Riaz isExperienced. Learn about Lung Nodules.
- Myelodysplastic Syndrome (MDS)Dr. Riaz isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- Non-Muscle Invasive Bladder CancerDr. Riaz isExperienced. Learn about Non-Muscle Invasive Bladder Cancer.
- Pulmonary EmbolismDr. Riaz isExperienced. Learn about Pulmonary Embolism.
- Sickle Cell DiseaseDr. Riaz isExperienced. Learn about Sickle Cell Disease.
- ThrombocytopeniaDr. Riaz isExperienced. Learn about Thrombocytopenia.
- Upper Tract Urothelial Carcinoma (UTUC)